NCT00696943 2013-02-15
18F ML-10 for Early Detection of Response of Brain Metastases to SRS
Aposense Ltd.
Phase 2 Terminated
Clinical Trials
3 trialsNCT00791063 2013-02-13
18F ML-10 for Early Detection of Response of Brain Metastases to WBRT
Aposense Ltd.
Phase 2 Completed
NCT00805636 2010-05-12
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Aposense Ltd.
Phase 2 Unknown